Citigroup (NYSE:C – Get Free Report) is one of 925 public companies in the “Banks” industry, but how does it compare to its competitors? We will compare Citigroup to related companies based on the strength of its institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Risk and Volatility Citigroup has a beta of […]

Oncocyte (NASDAQ:IMDX – Get Free Report) is one of 856 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Oncocyte to related companies based on the strength of its institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Profitability This table compares Oncocyte and its competitors’ […]